Hyperlipoproteinemia Type II - 29 Studies Found
Terminated |
: Efficacy and Tolerability of Anacetrapib Added to Ongoing Lipid-Lowering Therapy in Adult Participants With Homozygous Familial Hypercholesterolemia (HoFH) (MK-0859-042) :
|
Active, not recruiting |
: Study to Assess the Tolerability and Efficacy of Anacetrapib Co-administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020) :
|
Completed |
: Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia :
: 2014-03-27 :
|
Completed |
: Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578) :
|
Not yet recruiting |
: Study in Participants ≥12 Years of Age With Homozygous Familial Hypercholesterolemia (hoFH) : Homozygous Familial Hypercholesterolemia : 2017-05-15 :
|
Recruiting |
: A Registration Study for Familial Hypercholesterolemia in Taiwan : Familial Hypercholesterolemia : 2017-05-11 |
Recruiting |
: Greek Registry - Familial Hypercholesterolaemia : Familial Hypercholesterolemia : 2017-05-02 |
Not yet recruiting |
: HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia : Homozygous Familial Hypercholesterolemia : 2017-04-26 : Device: HDL Therapeutics PDS-2 System Delipidation of plasma HDL to reduce coronary atheroma |
Recruiting |
: Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) : Heterozygous Familial Hypercholesterolemia : 2017-01-30 :
|
Recruiting |
: Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia : Hypercholesterolemia, Familial : 2017-01-10 |